
浏览全部资源
扫码关注微信
第三军医大学第三附属医院肿瘤中心
纸质出版日期:2016,
扫 描 看 全 文
[1]杨怡,许明芳,熊艳丽,杨雪琴.体部伽玛刀治疗原发性肝癌伴门静脉癌栓疗效分析[J].重庆医科大学学报,2016,41(10):1087-1090.
Yang Yi, Xu Mingfang, Xiong Yanli, et al. Efficacy of gamma ray treatment for hepatocellular carcinoma with portal vein tumor thrombosis[J]. Journal of Chongqing Medical University, 2016,41(10):1087-1090.
[1]杨怡,许明芳,熊艳丽,杨雪琴.体部伽玛刀治疗原发性肝癌伴门静脉癌栓疗效分析[J].重庆医科大学学报,2016,41(10):1087-1090. DOI: 10.13406/j.cnki.cyxb.001035.
Yang Yi, Xu Mingfang, Xiong Yanli, et al. Efficacy of gamma ray treatment for hepatocellular carcinoma with portal vein tumor thrombosis[J]. Journal of Chongqing Medical University, 2016,41(10):1087-1090. DOI: 10.13406/j.cnki.cyxb.001035.
目的:探讨体部伽玛刀治疗原发性肝癌伴门静脉癌栓(portal vein tumor thrombosis
PVTT)的临床疗效。方法:在64例经CT/MR证实伴有PVTT的肝癌患者中
28例未接受任何治疗
36例针对癌栓行伽玛射线立体定向放疗
以50%
7
0%等剂量曲线覆盖靶区边缘
分割照射剂量3
5
Gy/次
5次/周
共治疗10次
总照射剂量30
5
0 Gy。并随访观察其近期疗效及生存率。结果:伽玛刀治疗组癌栓治疗有效率(objective response rate
ORR)为63.9%
其中完全缓解(complete response
CR)9例(25%)
部分缓解(partial response
PR)14例(38.9%)
疾病稳定(stable disease
SD)6例(16.7%)
疾病进展(progressive disease
PD)7例(19.4%)。患者1年生存率为36.1%
2年生存率为8.3%
中位生存期为10个月。而未治疗组病灶稳定3例(10.7%)
进展25例(89.3%)
1年和2年生存率均为0
中位生存期为3个月。结论:伽玛刀治疗原发性肝癌伴PVTT安全有效、毒副反应轻
能延长患者生存期。
Objective:To evaluate the effect of gamma knife radiosurgery on primary hepatic carcinoma with portal vein tumor thrombosis(PVTT). Methods:Totally 64 unrecsectable patients with PVTT diagnosis by CT/MR scan were reviewed;28 patients did not receive any treatment and other 36 patients were treated with gamma knife stereotaxis radiation therapy. A total of 30-50 Gy dose was prescribed to 50%-70% isodose line and performed in 10 fractions of 3-5 Gy each time. The short-term herapeutic effects and survival time was observed. Results:In gamma knife treatment group
9 patients(25%) achieved complete response(CR)
14(38.9%)achieved partial response(PR)
6(16.7%)had stable disease(SD)and 7 patients(19.4%)had progressive disease(PD). The objective response rate(ORR)was 63.9%. The overall survival rates of 1 year and 2 years were 36.1% and 8.3% respectively
with a median survival time of 10 months. In non-treatment group
3 patients(10.7%)achieved a SD and 25(89.3%)achieved a PD. The 1 year and 2 years survival rates were 0
with a median survival time of 3 months. Conclusion:Gamma knife radiosurgery
which has mild adverse reaction and can prolong the survival time is a safe and effective method for primary hepatic carcinoma with portal vein tumor thrombosis.
原发性肝癌门脉癌栓伽玛刀
Primary hepatic carcinomaportal vein tumor thrombusgamma ray treatment
0
浏览量
62
下载量
2
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621